Background and aims
===================

The introduction of Duke's criteria and the improvement of imaging methods has lead to diagnosing infectious endocarditis (IE) earlier and more accurately. Choosing the exact therapeutic approach and the timing of surgery are still a matter of debate and require a close collaboration between the cardiologist, the infectionist and the cardiac surgeon.

The surgical treatment of active infectious endocarditis still presents a high mortality and morbidity. Consequently there are still controversies regarding the timing of surgery, either in the active phase of IE or after the completion of the antibiotic therapy and the full regression of the infectious process \[[@b1-cm-88-338],[@b2-cm-88-338]\].

The main issue concerns surgical sanction before the onset of haemodinamic degradation: patients who meet the criteria for emergency will be operated in full acute process, patients who do not meet the emergency criteria will receive antibiotic therapy under constant clinical and ultrasound monitoring \[[@b1-cm-88-338],[@b3-cm-88-338]\].

This paper presents our clinical experience in the treatment of acute IE on native valves.

Patients and methods
====================

We undertook a retrospective, descriptive study, spanning over a period of five years (January 1st 2007, to December 31st, 2012). Of the patients operated for IE during this period, we took into consideration only those with native valve IE -- 100 patients.

For data collection we used the observation sheets, operative protocols, the electronic data-base of the institution, and the outpatient consultation registry. For statistical analysis we used the resources of the Microsoft Office Suite.

Results
=======

The patients' age varied between 13 and 77 years (with a mean of 54 years), of which 85 were males (85%); 37 patients (37%)T came from a rural environment. In 56 cases (56%) we succeeded in identifying the microorganism responsible for the IE (positive hemocultures). The main microorganisms responsible were: Streptococcus Spp. (21 cases -- 21%), Staphylococcus Spp. (15 cases -- 15%), Enterococcus Spp. (9 cases -- 9%) ([Table I](#tI-cm-88-338){ref-type="table"}).

We administered antibiotic therapy to all patients according to the indications of the infectious disease specialist (adapted to renal and liver function) as follows: in patients with positive hemocultures, according to the antibiogram, in patients with negative antibiogram -- empiric treatment with a broad spectrum to cover both Gram negative and Gram positive bacteria (quinolones or aminoglycosides combined with cephalosporine or vancomycine), chosen considering the clinical aspect and the potential entrance point.

The duration of antibiotic therapy ranged from 0 to over 43 days. Most patients (66 cases -- 66%) received between 3 and 6 weeks of antibiotic treatment, 10 patients (10%) received between 0 and 7 days of treatment (they met the criteria for emergency surgical treatment). The potential source of infection was identified in 26 patients (26%), with most cases being in the dental area (16 cases -- 16%) ([Table II](#tII-cm-88-338){ref-type="table"}).

The lesions caused by IE were situated in the left heart in 96 patients (96%), mostly on the aortic valve (50 cases -- 50%), localized in both the left and the right heart in 3 cases (3%), and 1 case localized only on the tricuspid valve ([Table III](#tIII-cm-88-338){ref-type="table"}).

In most cases (82%) we found preexisting endocardial lesions which predisposed to the development of IE, most of them being degenerative valvular lesions (38 cases -- 38%) ([Table IV](#tIV-cm-88-338){ref-type="table"}).

In association with the IE lesions, 10 patients (10%) presented acute cardio-embolic events (6 cases of ischemic stroke, 1 case of spleen infarction, 3 cases of peripheral artery embolisms ), and 5 cases (5%) presented secondary septic determinations (cerebral abscess -- 2 cases, spleen abscess - 1 case, peripheral mycotic aneurysms -- 2 cases).

All patients benefited from trans-thoracic or trans- esophageal echocardiogram, in 44 patients (44%) we performed a pre-operative coronary angiography and in 11 patients we performed head or abdomen CT. Regarding the timing of surgery, 10 patients (10%) underwent emergency surgery (less than a week from the diagnosis) and 90 patients (90%) were operated after at least 10 days of antibiotic therapy.

We performed the following surgical procedures: surgery on a single valve - aortic valve replacement (37 cases mechanical, 3 cases biological), mitral valve replacement (19 cases, all mechanical), mitral valve repair in 1 case, surgery on more than one valve -- mitral and aortic valve replacement (17 mechanical and 3 biological), aortic and tricuspid valve replacement (mechanical respectively biological) in 1 case, 5 cases of aortic valve replacement with a mechanical valve associated with mitral valve repair, 2 case of aortic valve replacement with a biological valve associated with mitral valve repair, and one case of mitral valve replacement with a mechanical valve combined with De Vega procedure on the tricuspid valve. We also performed combined procedures: coronary by-pass surgery combined with valve replacement 8 cases (4 mitral and 4 aortic, all with mechanical valves), and 3 cases of valve replacement combined with congenital heart defect surgery (2 procedures of ventricular septum defect closure and 1 procedure of atrial septum defect closure) and one procedure of tricuspid valve replacement with a biological valve and VSD and ASD closure.

In 5 patients (5%) the bacteriological examination of valve pieces excised during surgery was positive. In 3 cases it matched the germ identified in the hemocultures, and in 2 cases it revealed another bacterium.

Early post-operative complications (less than 30 days from surgery) are presented in [Table V](#tV-cm-88-338){ref-type="table"}.

Early post-operatory mortality was 5 % (5 cases out of 100). In what concerns the 10 cases who benefited from emergency surgery the mortality was 30 % (3 cases out of 10). In [Table VI](#tVI-cm-88-338){ref-type="table"} we present particular details concerning the 5 patients who died.

Out of the 100 cases studied 5 cases (5%) returned in our clinic with a second IE process on a prosthetic valve. Of the 5 cases one patient died before surgery, we operated 4 cases. Out of these four, two died (50% mortality). The interval between the first surgical intervention of valvular replacement for IE and the second episode of IE on prosthetic valve was between 5 and 156 weeks. In none of these cases the microorganism responsible for prosthetic valve IE matched the one found in the first episode of native valve IE.

Discussion
==========

Identifying the microorganism responsible for IE is often difficult. In our study we identified the germ in only 56% of the cases. We can attribute this fact to the fact that most of the patients already received antibiotic treatment for other diseases (dental, urinary, pulmonary), before the hemoculture harvest. As described in literature \[[@b1-cm-88-338],[@b2-cm-88-338]\], the most frequent microorganisms responsible for native valve IE were gram positive cocci, belonging the Streptococcus group (21%) and to the Staphylococcus group (15%).

We administered antibiotic therapy to all patients according to the indications of the infectious disease specialist (changed and adjusted based on the renal and liver functions) as follows: in patients with positive hemocultures, according to the antibiogram, in patients with negative antibiogram -- empiric treatment with a broad spectrum to cover both Gram negative and Gram positive bacteria (a quinolone or an aminoglycoside combined with cephalosporine or vancomycine), chosen considering the clinical aspect and the potential entrance point.

Once the surgical indication has been made (evidence class I and II), there comes the matter of timing of the surgical intervention. As such we divide patients with IE into 3 groups: emergency, urgency and elective \[[@b4-cm-88-338],[@b5-cm-88-338]\]. Emergency implies undertaking the surgical intervention in less than 24 hours from the diagnosis and is applied in patients with: severe acute valve regurgitation or valvular obstruction with pulmonary edema or cardiogenic shock, or IE with cavity fistula or pericardial fistula with pulmonary edema or cardiogenic shock \[[@b6-cm-88-338]\].

Our approach concerning the moment and duration of the antibiotic therapy was as follows: in patients who were hemodynamically stable we preferred to administer at least 4 weeks of treatment, most patients (65%) received between 4 and 6 weeks of treatment; in a relatively small number of patients who underwent surgery the duration of antibiotic treatment was under 7 days (10%). A number of 25 patients received between 1 and 3 weeks of treatment. At the moment of the diagnosis they did not meet the criteria for emergency so they were on antibiotic cure. During this period of clinical and echocardiographical monitoring they showed hemodynamical deterioration or the imaging aspect changed, which lead to emergent surgery before completing the minimum of 4 weeks of antibiotic treatment.

In many cases it was difficult to establish precisely the point of entry. In our study it was identified in only 26% of the cases, most of the times (16%) in the dental area. Moreover, the surgery was delayed because they had to be sterilized. The vast majority of IE lesions were located in the left heart (96%), involving mostly the aortic valve. As expected, in 82% of the cases the IE process appeared in the context of preexisting endocardial lesions.

Cerebrovascular complications occurred in 12--40% of patients during the active course of infective endocarditis (IE) \[[@b6-cm-88-338],[@b7-cm-88-338]\]. The timing of cardiac surgery of IE patients with neurological complications is controversial. Cardiopulmonary bypass (CPB) may exacerbate neurological deficits. Systemic heparinization may extend brain haemorrhage and convert brain infarction to haemorrhagic infarction \[[@b8-cm-88-338]\]. Hypotension during CPB may aggravate pre-existing ischaemic neurological injury, and CPB may potentiate cerebral edema in areas of blood-brain barrier disruption. Cerebral infarction, the most common of the neurological complications associated with IE, complicated the outcome of left-sided IE in 20--40% of patients \[[@b8-cm-88-338],[@b9-cm-88-338]\]. Eishi and associates reported the mortality rate of 66.3% if the cardiac operation was performed within 24 h after the onset of cerebral infarction \[[@b9-cm-88-338]\]. The risk of neurological deterioration after the valve replacement was calculated by Angstwurm et al. and they found that after brain infarction, the risk was 35% on Day 1, 15% on Days 2 and 3, 20--50% from Day 4 to Day 14, lower than 10% after 14 days and 0.4% after 4 weeks \[[@b4-cm-88-338]\]. Gillinov et al. recommended a delay of 2--3 weeks in performing cardiac surgery for patients with non-haemorrhagic embolic cerebrovascular accident \[[@b5-cm-88-338]\]. Piper et al. found the risk of deterioration to be low when cardiac surgery was performed within 72 h (when the blood-brain barrier was not yet altered) \[[@b10-cm-88-338]\]. Our approach in patients with native valve IE associated with neurological events (6 cases of stroke and 2 cases of cerebral abscess was as follows: in patients with stroke the cardiac procedure was performed 2--3 weeks after the onset of the neurological events; in patients who presented with cerebral abscess we preferred the neurosurgical correction of the cerebral lesion as a first step. We proceeded as such in one of the 2 cases where the cardiac procedure was performed 2 weeks after the brain surgery. In the other case, the condition of the patient (marked instability, acute severe mitral regurgitation, pulmonary edema) forced an emergency cardiac intervention as a first step, without brain surgery. The patient died 13 days after surgery.

There are still controversies about performing coronary angiography in patients with IE. A series of studies in literature approached this topic: *Kung V.W.S. et all, Interactive Cardiovascular ant Thoracic Surgery, 2011, Hekimian G. et all, Heart, 2010, Kilian E. et all, J. Thorac Cardiovasc Surg, 2008, Shamsham F. et all, Catheter Cardiovasc Interv, 2000, etc.* The majority have shown that it can be performed safely except for patients who are unstable and require emergency surgery \[[@b11-cm-88-338],[@b12-cm-88-338],[@b13-cm-88-338],[@b14-cm-88-338]\]. The European Society of Cardiology concluded in 2009 that coronary angiogram is recommended for: men over 40 years, post-menopause women, patients with at least one risk factor for coronary disease or with a history of cardiovascular disease, except for patients with large vegetations of the aortic valve, which might be dislodged during the procedure, and unstable patients who require emergency surgery. In our study 56% of the patients benefited from coronary angiogram: in some of these cases we had to perform emergency surgery and in others it was preferred not to be performed because of safety issues.

In only five cases (5%) the result of the bacteriological examination of endocardium fragments collected during surgery was positive. In 2 cases the result did not match that of the hemoculture obtained prior to surgery. In these cases the antibiotic was changed and continued 6 weeks. In all patients the antibiotic therapy was continued until the period of 6 weeks was finished. The fact that most of the valve cultures were negative translates to a good efficiency of the minimum of 4 weeks of antibiotic therapy.

Conclusion
==========

The overall mortality of 5% is well between the limits presented in literature, being high (30%) in patients with emergency surgery and in patients with prosthetic valve IE (50%).

###### 

The results for pre-operative hemocultures.

  Microorganism               Number of Patients (%)
  --------------------------- -------------------------------
  **Positive hemoculture**    **56 (56%)**
  Streptoccus spp.            21 (21%)
  Staphylococcus spp.         15 (15%)
   S. aureus                  8 (8%) (of which 4 were MRSA)
   S. epidermidis             2 (2%) (of which 1 was MRSE)
   Other Staphylococcus       5 (5%)
  Enterococcus spp.           9 (9%)
  Other microorganisms        10 (10%)
   *Enterobacter*             4 (4%)
   *Klebssiella pneumoniae*   4 (4%)
   *Serratia marescens*       1 (1%)
   *Chorynebacterium*         1 (1%)
  **Negative hemoculture**    **44 (44%)**

###### 

The entrance point for IE.

  Entrance point      Number of Patients (%)
  ------------------- ------------------------
  **Identified**      **26 (26%)**
  Dental              16 (16%)
  Pulmonary           3 (3%)
  Urinary             2 (2%)
  Dialysis catheter   1 (1%)
  Other               4 (4%)
  **Unidentified**    **74 (74%)**

###### 

Location of IE lesions.

  Location                       Number of Patients
  ------------------------------ --------------------
  **Left heart**                 **96**
  Mitral valve                   28
  Aortic valve                   50
  Mitral + aortic valve          18
  **Left heart + right heart**   **3**
  Mitral + tricuspid valve       1
  Aortic + tricuspid valve       2
  **Right heart**                **1**
  Tricuspid valve                1

###### 

Pre-existing cardiac lesions.

  Cardiac lesions         Number of Patients
  ----------------------- --------------------
  **Known**               **82**
  Degenerative            38
  \- aortic               28
  \- mitral               10
  Mitral valve prolapse   12
  Rheumatic disease       10
  Congenital              14
  \- aortic bicuspidy     8
  \- VSD                  2
  \- ASD                  4
  Prior cardiac surgery   2
  **Unknown**             **18**

###### 

Early complications after cardiac surgery for IE.

  Complication                                                                Number of Patients
  --------------------------------------------------------------------------- --------------------
  Early hemorrhage after surgery                                              13
  Aortic para-prosthetic leak which determined minor valvular insufficiency   10
  Mitral para-prosthetic leak which determined minor valvular insufficiency   6
  Presternal wound dehiscence                                                 5
  Sternal dehiscence                                                          2
  Mediastinitis                                                               1
  Pericardial effusion                                                        4
  Pleural effusion                                                            6
  Pneumothorax                                                                2
  Arrhythmia                                                                  22
   *- atrial fibrilation*                                                     17
   - III rd degree atrio-ventricular block                                    4
    - bradycardic jonctional rhythm                                           1
  Acute myocardial infarction                                                 1
  Post-operative stroke                                                       4
  Acute renal failure                                                         6
  Acute respiratory failure                                                   3
  Multiple system organ failure                                               1

###### 

Particular details concerning the 5 cases of death.

  Affected valve   Surgery                                                                 Emergency/Elective                                                                      Post-operatory complications                                                       Death cause
  ---------------- ----------------------------------------------------------------------- --------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------- -----------------------------------------------
  Ao+Mi            Mi+Ao valve replacement with mechanical valves                          **Emergency** (large vegetations, peripheral embolism)                                  Atrial fibrilation, fever, GI bleeding, MSOF                                       MSOF
  Ao               Ao valve replacement with mechanical valve                              **Emergency** (large vegetations, peripheral embolism)                                  Early post-op haemorrhage, left atrial thrombosis, stroke, masive cerebral edema   Massive cerebral edema
  Mi               Mi valve replacement with mechanical valve and CABG                     **Emergency** (Severe Mi regurgitation, pulmonary edema, acute myocardial infarction)   Atrial fibrilation, fever severe heart failure                                     Acute mtocardial infarction, cerebral abscess
  Ao               Ao valve replacement with mechanical valve                              **Elective**                                                                            \-                                                                                 Cardiac arrest (possibly rhythm abnormality)
  Ao               Ao valve replacement with mechanical valve and foramen ovalis closure   **Elective**                                                                            Atrial fibrilation, acute renal failure, severe heart failure                      Acute intestinal infarction

Deaths = 5/100 cases = 5%; Deaths in emergency cases = 3/10 cases = 30%
